Works matching IS 15257304 AND DT 2021 AND VI 22 AND IP 4

Results: 40
    1

    Table of Contents.

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 4, p. N.PAG, doi. 10.1016/S1525-7304(21)00154-6
    Publication type:
    Article
    2

    Editorial Board.

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 4, p. A1, doi. 10.1016/S1525-7304(21)00153-4
    Publication type:
    Article
    3
    4

    Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non–Small-Cell Lung Cancer (MYSTIC).

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 4, p. 301, doi. 10.1016/j.cllc.2021.02.010
    By:
    • Garon, Edward B.;
    • Cho, Byoung Chul;
    • Reinmuth, Niels;
    • Lee, Ki Hyeong;
    • Luft, Alexander;
    • Ahn, Myung-Ju;
    • Robinet, Gilles;
    • Le Moulec, Sylvestre;
    • Natale, Ronald;
    • Schneider, Jeffrey;
    • Shepherd, Frances A.;
    • Garassino, Marina Chiara;
    • Geater, Sarayut Lucien;
    • Szekely, Zsolt Papai;
    • Van Ngoc, Tran;
    • Liu, Feng;
    • Scheuring, Urban;
    • Patel, Nikunj;
    • Peters, Solange;
    • Rizvi, Naiyer A.
    Publication type:
    Article
    5

    A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non–small-cell Lung Cancer: SWOG 1206 (8811).

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 4, p. 313, doi. 10.1016/j.cllc.2021.02.009
    By:
    • Argiris, Athanassios;
    • Miao, Jieling;
    • Cristea, Mihaela C.;
    • Chen, Allen M.;
    • Sands, Jacob M.;
    • Decker, Roy H.;
    • Gettinger, Scott N.;
    • Daly, Megan E.;
    • Faller, Bryan A.;
    • Albain, Kathy S.;
    • Yanagihara, Ronald H.;
    • Garland, Linda L.;
    • Byers, Lauren A.;
    • Wang, Ding;
    • Koczywas, Marianna;
    • Redman, Mary W.;
    • Kelly, Karen;
    • Gandara, David R.
    Publication type:
    Article
    6
    7

    Activity and Immune Correlates of Programmed Death-1 Blockade Therapy in Patients With Advanced Large Cell Neuroendocrine Carcinoma.

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 4, p. 282, doi. 10.1016/j.cllc.2021.02.003
    By:
    • Shirasawa, Masayuki;
    • Yoshida, Tatsuya;
    • Takayanagi, Daisuke;
    • Shiraishi, Kouya;
    • Yagishita, Shigehiro;
    • Sekine, Katsutoshi;
    • Kanda, Shintaro;
    • Matsumoto, Yuji;
    • Masuda, Ken;
    • Shinno, Yuki;
    • Okuma, Yusuke;
    • Goto, Yasushi;
    • Horinouchi, Hidehito;
    • Hamada, Akinobu;
    • Kohno, Takashi;
    • Yamamoto, Noboru;
    • Watanabe, Shun-ichi;
    • Ohe, Yuichiro;
    • Motoi, Noriko
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14

    A Phase II Study to Assess the Efficacy of Osimertinib in Patients With EGFR Mutation-positive NSCLC Who Developed Isolated CNS Progression (T790M-negative or Unknown) During First- or Second-generation EGFR-TKI or Systemic Disease Progression (T790M-negative) After Treatment With First- or Second-generation EGFR-TKI and Platinum-based Chemotherapy (WJOG12819L)

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 4, p. 376, doi. 10.1016/j.cllc.2020.12.009
    By:
    • Takeda, Masayuki;
    • Shimokawa, Mototsugu;
    • Nakamura, Atsushi;
    • Nosaki, Kaname;
    • Watanabe, Yasutaka;
    • Kato, Terufumi;
    • Hayakawa, Daisuke;
    • Tanaka, Hiroshi;
    • Takahashi, Toshiaki;
    • Kogure, Yoshihito;
    • Tachihara, Motoko;
    • Fujimoto, Daichi;
    • Yamaguchi, Kakuhiro;
    • Hamaguchi, Naohiko;
    • Okamoto, Isamu;
    • Azuma, Koichi;
    • Hasegawa, Kazuo;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    15

    PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors.

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 4, p. 351, doi. 10.1016/j.cllc.2020.12.008
    By:
    • Ferrara, Miriam Grazia;
    • Martini, Maurizio;
    • D'Argento, Ettore;
    • Forcella, Chiara;
    • Vita, Emanuele;
    • Di Noia, Vincenzo;
    • Sperduti, Isabella;
    • Bilotta, Mirna;
    • Ribelli, Marta;
    • Damiano, Paola;
    • Cannella, Antonella;
    • Stefani, Alessio;
    • Pilotto, Sara;
    • Carbone, Carmine;
    • Piro, Geny;
    • Milella, Michele;
    • Tortora, Giampaolo;
    • Bria, Emilio
    Publication type:
    Article
    16

    Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non–Small-Cell Lung Cancer.

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 4, p. e637, doi. 10.1016/j.cllc.2020.12.007
    By:
    • Gregorc, Vanesa;
    • Mazzarella, Luca;
    • Lazzari, Chiara;
    • Graziano, Paolo;
    • Vigneri, Paolo;
    • Genova, Carlo;
    • Toschi, Luca;
    • Ciliberto, Gennaro;
    • Bonanno, Laura;
    • Delmonte, Angelo;
    • Bucci, Gabriele;
    • Rossi, Antonio;
    • Motta, Gianmarco;
    • Coco, Simona;
    • Marinello, Arianna;
    • Buglioni, Simonetta;
    • Cangi, Maria Giulia;
    • Di Micco, Concetta;
    • Bandiera, Alessandro;
    • Bonfiglio, Silvia
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Deep and Durable Response to Nivolumab and Temozolomide in Small-Cell Lung Cancer Associated With an Early Decrease in Myeloid-Derived Suppressor Cells.

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 4, p. e487, doi. 10.1016/j.cllc.2020.10.018
    By:
    • Owen, Dwight H.;
    • Benner, Brooke;
    • Pilcher, Carly;
    • Good, Logan;
    • Savardekar, Himanshu;
    • Norman, Ruthann;
    • Ghattas, Christian;
    • Shah, Manisha;
    • Konda, Bhavana;
    • Verschraegen, Claire F.;
    • Wesolowski, Robert;
    • Behbehani, Gregory K.;
    • Carson, William E.;
    • Otterson, Gregory A.
    Publication type:
    Article
    29
    30

    Nutritional Support in Lung Cancer Patients: The State of the Art.

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 4, p. e584, doi. 10.1016/j.cllc.2020.10.008
    By:
    • Mele, Maria Cristina;
    • Rinninella, Emanuele;
    • Cintoni, Marco;
    • Pulcini, Gabriele;
    • Di Donato, Agnese;
    • Grassi, Futura;
    • Trestini, Ilaria;
    • Pozzo, Carmelo;
    • Tortora, Giampaolo;
    • Gasbarrini, Antonio;
    • Bria, Emilio
    Publication type:
    Article
    31
    32
    33
    34
    35

    Trabectedin in Malignant Pleural Mesothelioma: Results From the Multicentre, Single Arm, Phase II ATREUS Study.

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 4, p. 361, doi. 10.1016/j.cllc.2020.06.028
    By:
    • Cortinovis, Diego;
    • Grosso, Federica;
    • Carlucci, Luciano;
    • Zucali, Paolo Andrea;
    • Pasello, Giulia;
    • Tiseo, Marcello;
    • Sperandi, Francesca;
    • Hollander, Lital;
    • Galli, Francesca;
    • Torri, Valter;
    • Rulli, Eliana;
    • Canova, Stefania;
    • Maconi, Antonio;
    • Bidoli, Paolo;
    • Ceresoli, Giovanni Luca;
    • D'Incalci, Maurizio
    Publication type:
    Article
    36
    37
    38
    39
    40